Response to "Nerve conduction studies support the classification of SARSCoV-2 associated Guillain-Barre subtypes"

Clin Exp Neuroimmunol. 2022 May;13(2):97-98. doi: 10.1111/cen3.12696. Epub 2022 Apr 4.

¹ Department of Medicine University of the Region of Joinville (UNIVILLE) Joinville Brazil.
² Neurology Service Internal Medicine Department Hospital Municipal São José Joinville Brazil.

No abstract available

Keywords: COVID‐19 vaccines; ChAdOx1 COVID‐19 vaccine; Guillain‐Barre syndrome; peripheral nervous system diseases.